Continue to Successfully Manage G&A

ir_statement / Sep 15, 2026 / receipt

Reduce Capital Spend and Funding Needs while Prioritizing Capital Necessary to Lease Space

ir_statement / Sep 15, 2026 / receipt

CONTINUED SUCCESSFUL MANAGEMENT OF G&A EXPENSES

ir_statement / Sep 15, 2026 / receipt

CONTINUED SUCCESSFUL MANAGEMENT OF G&A EXPENSES

ir_statement / Sep 15, 2026 / receipt

Non-income-producing assets for 2Q26 are 16% of gross assets, a 4% reduction since 4Q24; targeting a range of 11% to 16% by 4Q26.

ir_statement / Sep 15, 2026 / receipt

The lease enables us to pivot a portion of the redevelopment project from future laboratory and/or biomanufacturing use to a lower-cost advanced technology use, reducing the project’s expected aggrega

ir_statement / Sep 15, 2026 / receipt

We continue to evaluate the business and financial strategy for five projects aggregating 1.4 million RSF, which may allow us to further reduce future construction funding requirements within our acti

ir_statement / Sep 15, 2026 / receipt

Compared to 2024, we continue to expect approximately $76 million of cumulative general and administrative expense savings in 2025 and 2026 (based on the midpoint of our 2026 guidance range).

ir_statement / Sep 15, 2026 / receipt

For the trailing twelve months ended June 30, 2026, our general and administrative expenses represented 6.6% of net operating income, approximately half the average of other S&P 500 REITs for 2023-202

ir_statement / Sep 15, 2026 / receipt

General and administrative expenses for 2Q26 aggregated $36.9 million, an increase of $7.7 million, or 26.5%, from 2Q25, but a decrease of $7.8 million, or 17.4%, from 2Q24, reflecting the continued b

ir_statement / Sep 15, 2026 / receipt

If we elect to pursue lower-investment construction alternatives (including a pivot to advanced technology use), these projects could deliver earlier than 2028. The incremental capital required for al

ir_statement / Sep 15, 2026 / receipt

The $6.40 midpoint of the guidance range for 2026 funds from operations per share - diluted, as adjusted, remains unchanged

ir_statement / Sep 15, 2026 / receipt